UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

Annals of surgical oncology, 2022-05, Vol.29 (5), p.2882-2894

2022

Volltextzugriff (PDF)

ASO Visual Abstract: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

Annals of surgical oncology, 2022-05, Vol.29 (5), p.2897-2898

2022

Volltextzugriff (PDF)

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

Annals of surgical oncology, 2022-05, Vol.29 (5), p.3064-3064

2022

Volltextzugriff (PDF)

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

The lancet oncology, 2017-10, Vol.18 (10), p.1373-1385

2017

Volltextzugriff (PDF)

QLTI-09. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK: UPDATED INFO AFTER 17 MONTHS OF UTILIZATION

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v246-v247

2023

Volltextzugriff (PDF)

Abstract CT064: Intranasal brain delivery using NEO100 for recurrent glioblastoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT064-CT064

2019

Volltextzugriff (PDF)

Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2057-2057

2023

Volltextzugriff (PDF)

NCMP-07. CASE SERIES OF REGULARLY SCHEDULED MANNITOL INFUSIONS SHOWING WITH PROLONGED CLINICAL BENEFIT FOR MANAGEMENT OF CEREBRAL EDEMA IN GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii192-vii192

2022

Volltextzugriff (PDF)

NCOG-33. GLIOBLASTOMA AND PARKINSONISM, IS DEPLETED DOPAMINE A PROTECTIVE SURVIVAL FACTOR? A CASE SERIES OF 3 GBM PATIENTS

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v221-v221

2023

Volltextzugriff (PDF)

DDEL-08. MEGADOSE BOSWELLIA SERRATA CAUSES SIGNIFICANT DECREASE IN CEREBRAL EDEMA WITH MINIMAL TOXICITY IN BRAIN TUMOR PATIENTS

Neuro-oncology (Charlottesville, Va.), 2024-11, Vol.26 (Supplement_8), p.viii122-viii122

2024

Volltextzugriff (PDF)

QLTI-26. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii240-vii240

2022

Volltextzugriff (PDF)

QOL-14. INTEGRATING A TECHNOLOGY-ENABLED PLATFORM FOR PATIENT REPORTED OUTCOMES INTO A NEURO-ONCOLOGY PRACTICE

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v251-v251

2023

Volltextzugriff (PDF)

QOL-28. THE LIVED EXPERIENCE OF PATIENTS WITH CHORDOMA – A RETROSPECTIVE CASE SERIES

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v255-v255

2023

Volltextzugriff (PDF)

EOLP-07. A REAL-WORLD INTEGRATED OUTPATIENT PALLIATIVE AND SUPPORTIVE CARE CLINIC IN A REGIONAL COMMUNITY NEURO-ONCOLOGY PRACTICE

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v114-v114

2023

Volltextzugriff (PDF)

Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001 TGF-ß Trap

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2550-2550

2023

Volltextzugriff (PDF)

P12 - Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E27-E28

2019

Volltextzugriff (PDF)

Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

International journal of radiation oncology, biology, physics, 2019-04, Vol.103 (5), p.E27-E28

2019

Volltextzugriff (PDF)

DDRE-09. MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi76-vi76

2021

Volltextzugriff (PDF)

INNV-23. CASE REPORT OF CISPLATIN + ETOPOSIDE FOR THE TREATMENT OF METASTATIC MALIGNANT MENINGIOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi110-vi110

2021

Volltextzugriff (PDF)

QLTI-22. IMPROVING BRAIN CANCER PATIENT ACCESS TO CLINICAL TRIALS ACROSS SEVEN COMMUNITY HOSPITALS, THE PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii239-vii239

2022

Volltextzugriff (PDF)

CTNI-51. FEASIBILITY AND SAFETY OF NEUROSURGICAL RESECTION AND INTRA-OPERATIVE RADIATION THERAPY USING THE XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii83-vii84

2022

Volltextzugriff (PDF)

CTNI-15. PILOT STUDY OF HIGH-DOSE PEMETREXED FOR PROGRESSIVE CHORDOMA

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v76-v76

2023

Volltextzugriff (PDF)

MNGI-05. COMBINED MULTIMODAL TREATMENT REGIMEN IN RECURRENT MENINGIOMAS

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi140-vi140

2019

Volltextzugriff (PDF)

Using Cerebrospinal Fluid (CSF) tumor cells to track disease burden and treatment response in patients with Leptomeningeal Disease (LMD) from solid cancers (P13-9.006)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAF V600E glioblastoma results in sustained response: A case report

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae110

2024

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(49)
Berichte
(3)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

ASO Visual Abstract: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

QLTI-09. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK: UPDATED INFO AFTER 17 MONTHS OF UTILIZATION

Abstract CT064: Intranasal brain delivery using NEO100 for recurrent glioblastoma

Prospective phase I study of checkpoint blockade for the treatment of patients with newly diagnosed high-grade glioma prior to radiochemotherapy: Results of nivolumab plus ipilimumab treatment arm

NCMP-07. CASE SERIES OF REGULARLY SCHEDULED MANNITOL INFUSIONS SHOWING WITH PROLONGED CLINICAL BENEFIT FOR MANAGEMENT OF CEREBRAL EDEMA IN GLIOMAS

NCOG-33. GLIOBLASTOMA AND PARKINSONISM, IS DEPLETED DOPAMINE A PROTECTIVE SURVIVAL FACTOR? A CASE SERIES OF 3 GBM PATIENTS

DDEL-08. MEGADOSE BOSWELLIA SERRATA CAUSES SIGNIFICANT DECREASE IN CEREBRAL EDEMA WITH MINIMAL TOXICITY IN BRAIN TUMOR PATIENTS

QLTI-26. INTEGRATION OF NEURO-ONCOLOGY CLINICAL PATHWAYS IN PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

QOL-14. INTEGRATING A TECHNOLOGY-ENABLED PLATFORM FOR PATIENT REPORTED OUTCOMES INTO A NEURO-ONCOLOGY PRACTICE

QOL-28. THE LIVED EXPERIENCE OF PATIENTS WITH CHORDOMA – A RETROSPECTIVE CASE SERIES

EOLP-07. A REAL-WORLD INTEGRATED OUTPATIENT PALLIATIVE AND SUPPORTIVE CARE CLINIC IN A REGIONAL COMMUNITY NEURO-ONCOLOGY PRACTICE

Initial results from a first in human dose escalation trial of a novel immune stimulating oncolytic adenovirus, AdAPT-001 TGF-ß Trap

P12 - Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

Limited Margin Radiation Does Not Affect Patterns of Failure in Glioblastoma Patients Undergoing Concurrent Temozolamide Therapy

DDRE-09. MULTI-INSTITUTION RETROSPECTIVE EXPERIENCE WITH LENVATINIB FOR PROGRESSIVE MALIGNANT GLIOMA

INNV-23. CASE REPORT OF CISPLATIN + ETOPOSIDE FOR THE TREATMENT OF METASTATIC MALIGNANT MENINGIOMA

QLTI-22. IMPROVING BRAIN CANCER PATIENT ACCESS TO CLINICAL TRIALS ACROSS SEVEN COMMUNITY HOSPITALS, THE PROVIDENCE SOUTHERN CALIFORNIA CLINICAL RESEARCH NETWORK

CTNI-51. FEASIBILITY AND SAFETY OF NEUROSURGICAL RESECTION AND INTRA-OPERATIVE RADIATION THERAPY USING THE XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

CTNI-15. PILOT STUDY OF HIGH-DOSE PEMETREXED FOR PROGRESSIVE CHORDOMA

MNGI-05. COMBINED MULTIMODAL TREATMENT REGIMEN IN RECURRENT MENINGIOMAS

Using Cerebrospinal Fluid (CSF) tumor cells to track disease burden and treatment response in patients with Leptomeningeal Disease (LMD) from solid cancers (P13-9.006)

Neoadjuvant combination treatment with checkpoint inhibitors, chemotherapy, and BRAF/MEK inhibitors for BRAF V600E glioblastoma results in sustained response: A case report

Aktive Filter

Suchergebnisse filtern